Intercorrelation of Molecular Biomarkers and Clinical Phenotype Measures in Fragile X Syndrome.


Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
24 07 2023
Historique:
received: 18 05 2023
revised: 05 07 2023
accepted: 13 07 2023
medline: 31 7 2023
pubmed: 29 7 2023
entrez: 29 7 2023
Statut: epublish

Résumé

This study contributes to a greater understanding of the utility of molecular biomarkers to identify clinical phenotypes of fragile X syndrome (FXS). Correlations of baseline clinical trial data (molecular measures-

Identifiants

pubmed: 37508583
pii: cells12141920
doi: 10.3390/cells12141920
pmc: PMC10377864
pii:
doi:

Substances chimiques

Fragile X Mental Retardation Protein 139135-51-6
Biomarkers 0
RNA, Messenger 0
FMR1 protein, human 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NICHD NIH HHS
ID : P50 HD103526
Pays : United States
Organisme : NICHD NIH HHS
ID : NICHD P50 HD103526
Pays : United States

Références

Neuropsychopharmacology. 2012 Jan;37(1):178-95
pubmed: 21796106
Assessment. 2020 Sep;27(6):1258-1271
pubmed: 30991820
Am J Med Genet A. 2021 May;185(5):1448-1460
pubmed: 33605062
J Dev Behav Pediatr. 2007 Apr;28(2):133-8
pubmed: 17435464
Neurology. 2013 Mar 12;80(11 Suppl 3):S76-86
pubmed: 23479549
Med Care. 1999 Feb;37(2):126-39
pubmed: 10024117
J Med Genet. 2009 Feb;46(2):94-102
pubmed: 18835858
J Neurodev Disord. 2020 Mar 24;12(1):10
pubmed: 32204695
Curr Pediatr Rev. 2019;15(4):251-258
pubmed: 31241016
Neuropsychology. 2008 Jan;22(1):36-47
pubmed: 18211154
J Autism Dev Disord. 2012 Jul;42(7):1377-92
pubmed: 21972117
Nat Neurosci. 2013 Nov;16(11):1530-6
pubmed: 23584741
Neurobiol Dis. 2020 Mar;136:104740
pubmed: 31927143
Am J Med Genet B Neuropsychiatr Genet. 2008 Oct 5;147B(7):1253-7
pubmed: 18452182
Pediatrics. 2011 May;127(5):994-1006
pubmed: 21518720
Front Cell Neurosci. 2014 Mar 27;8:81
pubmed: 24733999
Neural Plast. 2018 Oct 3;2018:8423420
pubmed: 30402088
Genes (Basel). 2022 Jan 30;13(2):
pubmed: 35205326
Am J Hum Genet. 2000 Jan;66(1):6-15
pubmed: 10631132
J Mol Diagn. 2008 Jan;10(1):43-9
pubmed: 18165273
Neurology. 2020 Mar 24;94(12):e1229-e1240
pubmed: 32094241
Int Rev Res Dev Disabil. 2022;62:191-225
pubmed: 36213318
Curr Genomics. 2011 May;12(3):216-24
pubmed: 22043169
Res Dev Disabil. 2021 May;112:103912
pubmed: 33639603
Genes Brain Behav. 2012 Apr;11(3):332-41
pubmed: 22268788
Sleep. 2000 Dec 15;23(8):1043-51
pubmed: 11145319
Trends Mol Med. 2010 Nov;16(11):516-27
pubmed: 20864408
Dev Neurosci. 2011;33(5):337-48
pubmed: 21893938
Genome Med. 2012 Dec 21;4(12):100
pubmed: 23259642
J Neurodev Disord. 2016 Sep 06;8(1):35
pubmed: 27602170
Am J Med Genet A. 2022 Mar;188(3):858-866
pubmed: 35148024
Neurotherapeutics. 2015 Jul;12(3):584-608
pubmed: 25986746
Am J Med Genet. 1999 May 28;84(3):250-61
pubmed: 10331602
Neurosci Biobehav Rev. 2014 Oct;46 Pt 2:256-69
pubmed: 24184744
Brain Sci. 2019 Apr 27;9(5):
pubmed: 31035599
Cell. 2008 Sep 19;134(6):1042-54
pubmed: 18805096
PLoS One. 2019 Dec 31;14(12):e0226811
pubmed: 31891607
Neurology. 2023 Feb 21;100(8):e778-e789
pubmed: 36460468
J Dev Behav Pediatr. 2013 May;34(4):245-51
pubmed: 23669871
Int J Mol Sci. 2022 Feb 09;23(4):
pubmed: 35216055
J Neurodev Disord. 2019 Dec 26;11(1):41
pubmed: 31878865
J Cell Biol. 2008 Mar 10;180(5):1021-35
pubmed: 18332222
J Neurosci. 2013 Nov 13;33(46):18234-41
pubmed: 24227732
Am J Med Genet A. 2013 Aug;161A(8):1897-903
pubmed: 23824974
Annu Rev Pathol. 2012;7:219-45
pubmed: 22017584
Neuropsychopharmacology. 2019 Jan;44(2):324-333
pubmed: 30061744
Am J Med Genet A. 2014 Jul;164A(7):1648-58
pubmed: 24700618
J Autism Dev Disord. 2003 Dec;33(6):617-29
pubmed: 14714931
Nat Rev Neurosci. 2021 Apr;22(4):209-222
pubmed: 33608673
Nat Rev Dis Primers. 2017 Sep 29;3:17065
pubmed: 28960184
J Neurosci. 2007 Oct 3;27(40):10685-94
pubmed: 17913902
Front Genet. 2014 Oct 16;5:355
pubmed: 25360144
Clin Chem. 2010 Mar;56(3):399-408
pubmed: 20056738

Auteurs

Ramkumar Aishworiya (R)

MIND Institute, University of California Davis Medical Center, Sacramento, CA 95817, USA.
Khoo Teck Puat-National University Children's Medical Institute, National University Health System, Singapore 119074, Singapore.
Department of Pediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore.

Mei-Hung Chi (MH)

MIND Institute, University of California Davis Medical Center, Sacramento, CA 95817, USA.
Department of Psychiatry, National Cheng Kung University Hospital, Tainan 704, Taiwan.

Marwa Zafarullah (M)

Department of Biochemistry and Molecular Medicine, School of Medicine, University of California Davis, Sacramento, CA 95817, USA.

Guadalupe Mendoza (G)

Department of Biochemistry and Molecular Medicine, School of Medicine, University of California Davis, Sacramento, CA 95817, USA.

Matthew Dominic Ponzini (MD)

MIND Institute, University of California Davis Medical Center, Sacramento, CA 95817, USA.
Department of Public Health Sciences, School of Medicine, University of California Davis, Sacramento, CA 95817, USA.

Kyoungmi Kim (K)

MIND Institute, University of California Davis Medical Center, Sacramento, CA 95817, USA.
Department of Public Health Sciences, School of Medicine, University of California Davis, Sacramento, CA 95817, USA.

Hazel Maridith Barlahan Biag (HMB)

MIND Institute, University of California Davis Medical Center, Sacramento, CA 95817, USA.
Department of Pediatrics, School of Medicine, University of California Davis, Sacramento, CA 95817, USA.

Angela John Thurman (AJ)

MIND Institute, University of California Davis Medical Center, Sacramento, CA 95817, USA.
Department of Psychiatry and Behavioral Sciences, School of Medicine, University of California Davis, Sacramento, CA 95817, USA.

Leonard Abbeduto (L)

MIND Institute, University of California Davis Medical Center, Sacramento, CA 95817, USA.
Department of Psychiatry and Behavioral Sciences, School of Medicine, University of California Davis, Sacramento, CA 95817, USA.

David Hessl (D)

MIND Institute, University of California Davis Medical Center, Sacramento, CA 95817, USA.
Department of Psychiatry and Behavioral Sciences, School of Medicine, University of California Davis, Sacramento, CA 95817, USA.

Jamie Leah Randol (JL)

Department of Biochemistry and Molecular Medicine, School of Medicine, University of California Davis, Sacramento, CA 95817, USA.
Integrative Genetics and Genomics Graduate Group, University of California Davis, One Shields Avenue, Davis, CA 95616, USA.
UC Davis Biotechnology Program, University of California Davis, Davis, CA 95616, USA.

Francois V Bolduc (FV)

Department of Pediatrics, Department of Medical Genetics, Women and Children Health Research Institute, University of Alberta, Edmonton, AB T6G 2R3, Canada.

Sebastien Jacquemont (S)

CHU Sainte-Justine Research Center, Université de Montréal, Montreal, QC H3T 1J4, Canada.
Department of Pediatrics, University of Montreal, Montreal, QC H3T 1J4, Canada.

Sarah Lippé (S)

CHU Sainte-Justine Research Center, Université de Montréal, Montreal, QC H3T 1J4, Canada.
Department of Psychology, Université de Montréal, Montreal, QC H3T 1J4, Canada.

Paul Hagerman (P)

MIND Institute, University of California Davis Medical Center, Sacramento, CA 95817, USA.
Department of Biochemistry and Molecular Medicine, School of Medicine, University of California Davis, Sacramento, CA 95817, USA.

Randi Hagerman (R)

MIND Institute, University of California Davis Medical Center, Sacramento, CA 95817, USA.
Department of Pediatrics, School of Medicine, University of California Davis, Sacramento, CA 95817, USA.

Andrea Schneider (A)

MIND Institute, University of California Davis Medical Center, Sacramento, CA 95817, USA.
Department of Pediatrics, School of Medicine, University of California Davis, Sacramento, CA 95817, USA.

Flora Tassone (F)

MIND Institute, University of California Davis Medical Center, Sacramento, CA 95817, USA.
Department of Biochemistry and Molecular Medicine, School of Medicine, University of California Davis, Sacramento, CA 95817, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH